Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure

NCT01587222 is registered in ClinicalTrials.gov with Anna Cruceta as lead sponsor.

NCT NCT01587222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01587222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure
Lead sponsor
Anna Cruceta
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2016
Completion date
August 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, hepatorenal syndrome, renal failure